News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,353 Results
Type
Article (15211)
Company Profile (291)
Press Release (266851)
Section
Business (83040)
Career Advice (388)
Deals (13912)
Drug Delivery (38)
Drug Development (50835)
Employer Resources (45)
FDA (5940)
Job Trends (5779)
News (149619)
Policy (10426)
Tag
Academia (1032)
Alliances (22967)
Alzheimer's disease (821)
Antibody-drug conjugate (ADC) (75)
Approvals (5942)
Artificial intelligence (105)
Bankruptcy (103)
Best Places to Work (5208)
Biotechnology (239)
Breast cancer (132)
Cancer (1127)
Cardiovascular disease (89)
Career advice (330)
CAR-T (92)
Cell therapy (273)
Clinical research (40886)
Collaboration (457)
Compensation (189)
COVID-19 (1062)
C-suite (122)
Cystic fibrosis (75)
Data (1169)
Diabetes (109)
Diagnostics (1527)
Earnings (29922)
Events (49457)
Executive appointments (374)
FDA (6458)
Funding (426)
Gene editing (76)
Gene therapy (202)
GLP-1 (346)
Government (1158)
Healthcare (6980)
Infectious disease (1114)
Inflammatory bowel disease (106)
Interviews (73)
IPO (7492)
Job creations (917)
Job search strategy (270)
Layoffs (198)
Legal (1459)
Lung cancer (167)
Manufacturing (112)
Medical device (3034)
Medtech (3035)
Mergers & acquisitions (6666)
Metabolic disorders (324)
Neuroscience (1140)
NextGen: Class of 2025 (2268)
Non-profit (1119)
Northern California (1375)
Obesity (174)
Opinion (107)
Parkinson's disease (93)
Patents (87)
People (26442)
Phase I (14387)
Phase II (18998)
Phase III (12070)
Pipeline (509)
Postmarket research (866)
Preclinical (6039)
Radiopharmaceuticals (210)
Rare diseases (250)
Real estate (1587)
Regulatory (8700)
Research institute (1017)
Series A (85)
Southern California (1216)
Startups (2059)
United States (10924)
Vaccines (192)
Weight loss (99)
Date
Last 7 days (348)
Last 30 days (1460)
Last 365 days (20983)
2025 (2718)
2024 (21195)
2023 (23188)
2022 (28637)
2021 (30693)
2020 (26139)
2019 (17955)
2018 (12964)
2017 (14504)
2016 (12571)
2015 (15094)
2014 (10919)
2013 (7949)
2012 (8123)
2011 (8169)
2010 (7765)
Location
Africa (191)
Asia (17665)
Australia (2999)
California (3150)
Canada (980)
China (272)
Colorado (116)
Connecticut (135)
Europe (38462)
Florida (357)
Georgia (99)
Illinois (203)
Indiana (125)
Maryland (410)
Massachusetts (2464)
Minnesota (135)
New Jersey (767)
New York (851)
North Carolina (491)
Northern California (1375)
Ohio (114)
Pennsylvania (585)
South America (252)
Southern California (1216)
Texas (350)
Washington State (297)
282,353 Results for "solve therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Solve Therapeutics, Inc. Acquires Cereius, Inc., a Duke University Spin-Out
Solve Therapeutics, Inc. announces the acquisition of Cereius, Inc.
June 22, 2023
·
4 min read
Press Releases
Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science’s Biggest Challenges
November 15, 2024
·
2 min read
Press Releases
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
September 11, 2024
·
7 min read
Business
Nerviano Medical Sciences Announces Licensing of Linker-Payload Technology to Solve Therapeutics to Develop and Commercialize Novel Antibody-Drug Conjugates.
Nerviano Medical Sciences S.r.l. (NMS) announced signing of a license agreement and right of option with Solve Therapeutics, Inc. (SolveTx) to develop and commercialize novel antibody-drug conjugates (ADCs) for up to four cancer targets selected by SolveTx.
June 5, 2023
·
6 min read
Biotech Bay
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the creation of the HiFi Solves consortium.
November 2, 2023
·
6 min read
DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy
QIAGEN and DNA Labs International announced that DLI has recently solved two decades-old “cold cases” using QIAGEN solutions.
November 30, 2023
·
9 min read
Bio NC
Bright Path Labs is Solving Drug Shortages with Domestic Development and Manufacturing of Cancer Medicines
Bright Path Laboratories, a US-based advanced drug development and manufacturing company is proud to announce their contribution to solving drug shortages for the domestic development and manufacturing of two critical cancer drugs: Carboplatin and Cisplatin.
December 13, 2023
·
1 min read
SOLVE FSHD Announces New Collaborative Research Grants to Accelerate Novel Potential Therapeutics for Facioscapulohumeral Muscular Dystrophy (FSHD)
SOLVE FSHD, a venture philanthropy organization catalyzing innovation and removing barriers to accelerate new therapies for FSHD, announced today that it has awarded grants totalling USD $1.4M to four new collaborative research projects that address critical gaps in FSHD therapeutics, biology and/or biomarkers.
July 11, 2023
·
3 min read
Biotech Beach
Solve Therapeutics Announces Mission to Advance Novel Antibody-Based Therapies Against Cancer-Specific Targets
Solve Therapeutics, Inc. (SolveTx), an oncology-focused biopharmaceutical company, announced today its mission to develop novel antibody-based therapies targeting tumor-specific antigens.
December 14, 2022
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 28,236
Next
